Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

• Conditions: Hereditary Cancer

• Registration Number: NCT03319290
• Lead Sponsor: Data Collection Analysis Business Management

Brief Summary

Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.

Detailed Description

The general design of this study is collecting data and reviewing the Principal Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to their specific SOP.

Study Timeline

• Study Start: 2017-10-17
• Study First Submitted: 2017-10-17
• Study First Submitted QC: 2017-10-19
• Study First Posted: 2017-10-24
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-22
• Last Update Posted: 2019-01-23
• Primary Completion: 2020-10-01
• Study Completion: 2020-10-17

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• Must be a Medical Practitioner

  • Medical Doctor (MD)
  • Doctor of Osteopathic (DO)
  • Physician Assistant (PA)
  • Advanced Practice Registered Nurse (APRN)
  • Nurse Practitioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history

Exclusion Criteria

• Government-funded insurance data cannot be included in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Provider Structures and Processes	36 months	Plan of Care Changes due to BRCA testing. Provider based observational survey system on the health and well-being of patients and populations

Trial Locations

Locations (1)

DCABM; 🇺🇸 Land O' Lakes, Florida, United States